The Archer® FusionPlex® Oncology Research Kit is a targeted next generation sequencing (NGS) assay to simultaneously detect and identify fusions and other mutations associated with 74 genes found in RNA transcripts that are linked to various cancers. This kit is extensive and purpose-built to advance fusion discovery, including research efforts in the area of Ph-like ALL fusions.
Studies are performed from RNA extracted from several types of starting sample. Using Archer’s proprietary Anchored Multiplex PCR (AMP™)-based enrichment, fusions of all genes in this kit can be identified in a single sequencing assay, even without prior knowledge of fusion partners or breakpoints. Archer Analysis software allows the analysis and interpretation of the data.